Polypoidal Choroidal Vasculopathy: A Review

Survey of Ophthalmology

Volumn 55, Issue 6, 2010, Pages 501-515

  Imamura, Yutaka ^a   Engelbert, Michael ^a   Iida, Tomohiro ^b   Freund, K Bailey ^a   Yannuzzi, Lawrence A ^a  

^a EAR AND THROAT HOSPITAL   (United States)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Age related macular degeneration; Antivasogenic treatment; Fluorescein angiography; Genetics; Indocyanine green angiography; Optical coherence tomography; Pathogenesis; Photodynamic therapy; Polypoidal choroidal vasculopathy

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; BEVACIZUMAB; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C2; COMPLEMENT FACTOR H; PEPTIDASE; PROTEIN HTRA1; RANIBIZUMAB; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN INHIBITOR;

CLINICAL FEATURE; DEMOGRAPHY; DISEASE COURSE; DRUG EFFICACY; FLUORESCENCE ANGIOGRAPHY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; INDOCYANINE GREEN ANGIOGRAPHY; LASER COAGULATION; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PHOTODYNAMIC THERAPY; POLYPOIDAL CHOROIDAL VASCULOPATHY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RETINA HEMORRHAGE; REVIEW; TREATMENT RESPONSE; VISUAL ACUITY; VITRECTOMY;

ANGIOGENESIS INHIBITORS; CHOROID; CHOROID DISEASES; FLUORESCEIN ANGIOGRAPHY; HUMANS; PERIPHERAL VASCULAR DISEASES; PHOTOCHEMOTHERAPY; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 77957749204     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.survophthal.2010.03.004     Document Type: Review

References (118)

1. Abe S, Yamamoto T, Haneda S et al. Three-dimensional features of polypoidal choroidal vasculopathy observed by spectral-domain OCT. Ophthalmic Surg Lasers Imaging. 2010 [Epub ahead of print. doi: 10.3928/15428877-20100215-76].
2. Ahuja R.M., Downes S.M., Stanga P.E., et al. Polypoidal choroidal vasculopathy and central serous chorioretinopathy. Ophthalmology 2001, 108(6):1009-1010.
3. Ahuja R.M., Stanga P.E., Vingerling J.R., et al. Polypoidal choroidal vasculopathy in exudative and haemorrhagic pigment epithelium detachments. Br J Ophthalmol 2000, 84(5):479-484.
4. Akaza E., Mori R., Yuzawa M. Long-term results of photodynamic therapy of polypoidal choroidal neovascularization. Retina 2008, 28(5):712-722.
5. Bartlett H.M., Willoughby B., Mandava N. Idiopathic polypoidal choroidal vasculopathy in a patient with melanocytoma of the optic nerve. Retina 2001, 21(4):396-399.
6. Cackett P., Wong D., Yeo I. A classification system for polypoidal choroidal vasculopathy. Retina 2009, 29(2):187-191.
7. Chan W.M., Ds Lam, Lai T.Y., et al. Photodynamic therapy with verteporfin for systemic polypoidal choroidal vasculopathy: one-year results of a prospective case series. Ophthalmology 2004, 111(8):1576-1584.
8. Cho M., Barbazetto I.A., Freund K.B. Refractory neovascular age-related macular degeneration secondary to polypoidal choroidal vasculopathy. Am J Ophthalmol 2009, 148(1):70-78.
9. Ciardella A.P., Donsoff I.M., Huang S.J., et al. Polypoidal choroidal vasculopathy. Surv Ophthalmol 2004, 49(1):25-37.
10. Costa R.A., Navajas E.V., Farah M.F., et al. Polypoidal choroidal vasculopathy: angiographic characterization of the network vascular elements and a new treatment paradigm. Prog Retin Eye Res 2005, 24(5):560-586.
11. Dewan A., Liu M., Hartman S., et al. HTRA1 promoter polymorphism in wet age-related macular degeneration. Science 2006, 314(5801):989-992.
12. Eandi C.M., Ober M.D., Freund K.B., et al. Selective photodynamic therapy for neovascular age-related macular degeneration with polypoidal choroidal neovascularization. Retina 2007, 27(7):825-831.
13. Escaño M.F., Fujii S., Ishibashi K., et al. Indocyanine green videoangiography in macular variant of idiopathic polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2000, 44(3):313-316.
14. Fine H.F., Ferrara D.C., Ho I.-V., et al. Bilateral choroidal osteomas with polypoidal choroidal vasculopathy. Retin Cases Brief Rep 2008, 2(1):15-17.
15. Giovannini A., Amato G.P. D'Altobrando E, Giuliani M. Optical coherence tomography (OCT) in idiopathic polypoidal choroidal vasculopathy (IPCV). Doc Ophthalmol 1999, 97(3-4):367-371.
16. Gomez-Ulla F., Gonzalez F., Torreiro M.G. Diode laser photocoagulation in idiopathic polypoidal choroidal vasculopathy. Retina 1998, 18(5):481-483.
17. Gomi F., Sawa M., Mitarai K., et al. Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescence angiography. Graefes Arch Clin Exp Ophthalmol 2007, 245(10):1421-1427.
18. Gomi F., Ohji M., Sayanagi K., et al. One-year outcomes of photodynamic therapy in age-ralated macular degeneration and polypoidal choroidal vasculopathy in Japanese patients. Ophthalmology 2008, 115(1):141-146.
19. Gomi F., Sawa M., Sakaguchi H., et al. Efficacy of intravitreal bevacizumab for choroidal vasculopathy. Br J Ophthalmol 2008, 92(1):70-73.
20. Gomi F., Tano Y. Polypoidal choroidal vasculopathy and treatments. Curr Opin Ophthalmol 2008, 19(3):208-212.
21. Gotoh N., Nakanishi H., Hayashi H., et al. ARMS2(LOC387715) variants in Japanese patients with exudative age-related macular degeneration and polypoidal choroidal vasculopathy. Am J Ophthalmol 2009, 147(6):1037-1041.
22. Gotoh N., Kuroiwa S., Kikuchi T., et al. Apolipoprotein E polymorphisms in Japanese patients with polypoidal choroidal vasculopathy and exudative age-related macular degeneration. Am J Ophthalmol 2004, 138(4):567-573.
23. Gotoh N., Yamada R., Nakanishi H., et al. Correlation between Y402H and HTRA1 rs11200638 genotype to typical exudative age-related macular degeneration and polypoidal choroidal vasculopathy phenotype in the Japanese population. Clin Experiment Ophthalmol 2008, 36(5):437-442.
24. Ghajarnia M., Kurup S., Eller A. The therapeutic effects of intravitreal bevacizumab in a patient with recalcitrant idiopathic polypoidal choroidal vasculopathy. Semin Ophthalmol 2007, 22(2):127-131.
25. Hirami Y., Tsujikawa A., Otani A., et al. Hemorrhagic complications after photodynamic therapy for polypoidal choroidal vasculopathy. Retina 2007, 27(3):335-341.
26. Honda S., Imai H., Yamashiro K., et al. Comparative assessment of photodynamic therapy for typical age-related macular degeneration and polypoidal choroidal vasculopathy: a multicenter study in Hyogo prefecture. Japan. Ophthalmologica 2009, 223(5):333-338.
27. Iida T., Yannuzzi L.A., Freund K.B., et al. Retinal angiopathy and polypoidal choroidal vasculopathy. Retina 2002, 22(4):455-463.
28. Iijima H., Iida T., Imai M., et al. Optical coherence tomography of orange-red subretinal lesions in eyes with idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2000, 129(1):21-26.
29. Iijima H., Imai M., Gohdo T., et al. Optical coherence tomography of idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 1999, 127(3):301-305.
30. Imai H., Honda S., Nakanishi Y., et al. Different transitions of multifocal electroretinogram recording s between patients with age-related macular degeneration and polypoidal choroidal vasculopathy after photodynamic therapy. Br J Ophthalmol 2006, 90(12):1524-1530.
31. Iwama D., Tsujikawa A., Sasahara M., et al. Polypoidal choroidal vasculopathy with drusen. Jpn J Ophthalmol 2008, 52(2):116-121.
32. Kanda A., Chen W., Othman M., et al. A variant of mitochondrial protein LOC387715/ARMS2, not HTRA1, is strongly associated with age-related macular degeneration. Proc Natl Acad Sci USA 2007, 104(41):16227-16232.
33. Kikuchi M., Nakamura M., Ishikawa K., et al. Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration. Ophthalmology 2007, 114(9):1722-1727.
34. Kitamura T., Matsubara M., Yamada H., et al. Racemose haemangioma like choroidal neovascularization in indocyanine green angiography [Japanese]. Jpn J Clin Ophthalmol 1995, 49(2):208-210.
35. Kleiner R.C., Brucker A.J., Johnston R.L. The posterior uveal bleeding syndrome. Retina 1990, 10(1):9-17.
36. Kokame G.T., Yeung L., Lai J.C. Continuous anti-VEGF treatment with ranibizumab for polypoidal choroidal vasculopathy: an interim 6-month report. Br J Ophthalmol 2010, 94(3):297-301.
37. Kondo N., Honda S., Kuno S., et al. Codong variant I62V in the complement factor H gene is strongly associated with polypoidal choroidal vasculopathy. Ophthalmology 2009, 116(2):304-310.
38. Kondo N., Honda S., Ishibashi K., et al. Elastin gene polymorphism in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2008, 49(3):1101-1105.
39. Kondo N., Honda S., Ishibashi K., et al. LOC387715/HTRA1 variants in polypoidal choroidal vasculopathy and age-related macular degeneration in a Japanese population. Am J Ophthalmol 2007, 144(4):608-612.
40. Kuroiwa S., Tateiwa H., Hisatomi T., et al. Pathologic features of surgically excised polypoidal choroidal vasculopathy membranes. Clin Experiment Ophthalmol 2004, 32(3):297-302.
41. Kusashige Y., Otani A., Sasahara M., et al. Two-year results of photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2008, 146(4):513-519.
42. Kwok A.K., Lai T.Y., Chan C.W., et al. Polypoidal choroidal vasculopathy in Chinese patients. Br J Ophthalmol 2002, 86(6):892-897.
43. Ladas I.D., Rouvas A.A., Moschos M.M., et al. Polypoidal choroidal vasculopathy and exudative age-related macular degeneration in Greek population. Eye (Lond) 2004, 18(5):455-459.
44. Lai T.Y., Chan W.M., Liu D.T., et al. Intravireal bevacizumab (Avastin). with or without photodynamic therapy for the treatment of polypoidal choroidal vasculopathy. Br J Ophthalmol 2008, 92(5):661-666.
45. Lafaut B.A., Leys A.M., Snyers B., et al. Polypoidal choroidal vasculopathy in Caucasians. Graefes Arch Clin Exp Ophthalmol 2000, 238(9):752-759.
46. Lafaut B.A., Aisenbrey S., van den Broecke C., et al. Polypoidal choroidal vasculopathy pattern in age-related macular degeneration: a clinicopathological correlation. Retina 2000, 20(6):650-654.
47. Lee K.Y., Vithana E.N., Mathur R., et al. Association analysis of CFH, C2, BF, and HTRA1 gene polymorphisms in Chinese patients with polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2008, 49(6):2613-2619.
48. Lee S.Y., Kim J.G., Joe S.G., et al. The therapeutic effects of bevacizumab in patients with polypoidal choroidal vasculopathy. Korean J Ophthalmol 2008, 22(2):92-99.
49. Lee W.K., Lee P.Y., Lee S.K. Photodynamic therapy for polypoidal choroidal vasculopathy: vaso-occlusive effect on the branching vascular network and origin of recurrence. Jpn J Ophthalmol 2008, 52(2):108-115.
50. Li H., Wen F., Wu D. Polypoidal choroidal vasculopathy in a patient with circumscribed choroidal hemangioma. Retina 2004, 24(4):629-631.
51. Lima L.H., Schubert C., Ferrara D.C., et al. Three major loci involved in age-related macular degeneration are also associated with polypoidal choroidal vasculopathy. Ophthalmology 2010, 117(8):1567-1570.
52. Maruko I., Iida T., Saito M., et al. Clinical characteristics of exudative age-related macular degeneration in Japanese patients. Am J Ophthalmol 2007, 144(1):15-22.
53. Mauget-Faÿsse M., Cornut P.L., Quaranta El-Maftouhi M., et al. Polypoidal choroidal vasculopathy in tilted disk syndrome and high myopia with staphyloma. Am J Ophthalmol 2006, 142(6):970-975.
54. Mauget-Faÿsse M., Quaranta-El Maftouhi M., De La Marnierre E., et al. Photodynamic therapy with verteporfin in the treatment of exudative idiopathic polypoidal choroidal vasculopathy. Eur J Ophthalmol 2006, 16(5):695-704.
55. Moorthy R.S., Lyon A.T., Rabb M.F., et al. Idiopathic polypoidal choroidal vasculopathy of the macula. Ophthalmology 1998, 105(8):1380-1385.
56. Musashi K., Tsujikawa A., Hirami Y., et al. Microrips of the retinal pigment epithelium in polypoidal choroidal vasculopathy. Am J Ophthalmol 2007, 143(5):883-885.
57. Nakajima M., Yuzawa M., Shimada H., et al. Correlation between indocyanine green angiographic findings and histopathology of polypoidal choroidal vasculopathy. Jpn J Ophthamol 2004, 48(3):249-255.
58. Nakashizuka H., Mitsumata M., Okisaka S., et al. Clinicopathological findings of polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci 2008, 49(11):4729-4737.
59. Nishijima K., Takahashi M., Akita J., et al. Laser photocoagulation of indocyanine green angiographically identified feeder vessels to idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2004, 137(4):770-773.
60. Obata R., Yanagi Y., Kami J., et al. Polypoidal choroidal vasculopathy and retinochoroidal anastomosis in Japanese patients eligible for photodynamic therapy for exudative age-related macular degeneration. Jpn J Ophthalmol 2006, 50(4):354-360.
61. Ogino T., Takeda M., Imaizumi H., Okushiba U. Photodynamic therapy for age-related macular degeneration in Japanese patients: results after one year. Jpn J Ophthalmol 2007, 51(3):210-215.
62. Ojima Y., Tsujikawa A., Otani A., et al. Recurrent bleeding after photodynamic therapy in polypoidal choroidal vasculopathy. Am J Ophthalmol 2006, 141(5):958-960.
63. Okubo A., Hirakawa M., Ito M., et al. Clinical features of early and late stage polypoidal choroidal vasculopathy characterized by lesion size and disease duration. Graefes Arch Clin Exp Ophthalmol 2008, 246(4):491-499.
64. Okubo A., Ito M., Sameshima M., et al. Pulsatile blood flow in the polypoidal choroidal vasculopathy. Ophthalmology 2005, 112(8):1436-1441.
65. Okubo A., Ito M., Kamisasanuki T., Sakamoto T. Visual improvement following trans-Tenon's retrobulbar triamicinolone acetonide infusion for polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2005, 243(8):837-839.
66. Okubo A., Sameshima M., Sakamoto T. Plasticity of polypoidal lesions in polypoidal choroidal vasculopathy. Graefes Arch Clin Exp Ophthalmol 2004, 242(11):962-965.
67. Okubo A., Sameshima M., Uemura A., et al. Clinicopathological correlation of polypoidal choroidal vasculopathy revealed by ultrastructural study. Br J Ophthalmol 2002, 86(10):1093-1098.
68. Oshima Y., Ohji M., Tano Y. Pars plana vitrectomy with peripheral retinotomy after injection of preoperative intravitreal tissue plasminogen activator: a modified procedure to drain massive subretinal haemorrhage. Br J Ophthalmol 2007, 91(2):193-198.
69. Otani A., Sasahara M., Yodoi Y., et al. Indocyanine green angiography: guided photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2007, 144(1):7-14.
70. Ozawa S., Ishikawa K., Ito Y., et al. Differences in macular morphology between polypoidal choroidal vasculopathy and exudative age-related macular degeneration detected by optical coherence tomography. Retina 2009, 29(6):793-802.
71. Prakash M., Han D.P. Recurrent bullous retinal detachment from photodynamic therapy for idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 2006, 142(6):1079-1081.
72. Phillips W.B., Regillo C.D., Maguire J.I. Indocyanine green angiography of idiopathic polypoidal choroidal vasculopathy. Ophthalmic Surg Lasers 1996, 27(6):467-470.
73. Quaranta M., Mauget-Faÿsse M., Coscas G. Exudative idiopathic polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Am J Ophthalmol 2002, 134(2):277-280.
74. Reche-Frutos J., Calvo-Gonzales C., Donate-Lopez J., et al. Short-term anatomic effect of ranibizumab for polypoidal choroidal vasculopathy. Eur J Ophthalmol 2008, 18(4):645-648.
75. Rogers A.H., Greenberg P.B., Martidis A., Puliafito C.A. Photodynamic therapy of polypoidal choroidal vasculopathy. Ophthalmic Surg Lasers Imaging 2003, 34(1):60-63.
76. Rosa R.H., Davis J.L., Eifrig C.W. Clinicopathological correlation of idiopathic polypoidal choroidal vasculopathy. Arch Ophthalmol 2002, 120(4):502-508.
77. Saito M., Iida T., Nagayama D. Cross-sectional and en face optical coherence tomographic features of polypoidal choroidal vasculopathy. Retina 2008, 28(3):459-464.
78. Saito M., Iida T., Nagayama D. Photodynamic therapy with verteporfin for age-related macular degeneration or polypoidal choroidal vasculopathy: comparison of the presence of serous retinal pigment epithelial detachment. Br J Ophthalmol 2008, 92(12):1642-1647.
79. Sakurada Y., Kubota T., Mabuchi F., et al. Association of LOC387715 A69S with vitreous hemorrhage in polypoidal choroidal vasculopathy. Am J Ophthalmol 2008, 145(6):1058-1062.
80. Sasahara M., Tsujikawa A., Musashi K., et al. Polypoidal choroidal vasculopathy with choroidal vascular hyperpermeability. Am J Ophthalmol 2006, 142(4):601-607.
81. Sato T., Kishi S., Watanabe G., et al. Tomographic features of branching vascular networks in polypoidal choroidal vasculopathy. Retina 2007, 27(5):589-594.
82. Sayanagi K., Gomi F., Sawa M., et al. Long-term follow-up of polypoidal choroidal vasculopathy after photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 2007, 245(10):1569-1571.
83. Scassellati-Sforozolini B., Mariotti C., Bryan R., et al. Polypoidal choroidal vasculopathy in Italy. Retina 2001, 21(2):121-125.
84. Schneider U., Gelisken F., Kreissig I. Indocyanine green angiography of idiopathic polypoidal choroidal vasculopathy. Br J Ophthalmol 1998, 82:98-99.
85. Shima C., Gomi F., Sawa M., et al. One-year results of combined photodynamic therapy and intravitreal bevacizumab injection for retinal pigment epithelial detachment secondary to age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2009, 247(7):899-906.
86. Shiraga F., Matsuo T., Yokoe S., et al. Surgical treatment of submacular hemorrhage with idiopathic polypoidal choroidal vasculopathy. Am J Ophthalmol 1999, 128(2):147-154.
87. Sho K., Takahashi K., Yamada H., et al. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol 2003, 121(10):1392-1396.
88. Silva R.M., Figueura J., Cachulo M.L., et al. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 2005, 243(10):973-979.
89. Smith R.E., Wise K., Kingsley R.M. Idiopathic polypoidal choroidal vasculopathy and sickle cell retinopathy. Am J Ophthalmol 2000, 129(4):544-546.
90. Song J.H., Byeon S.H., Lee S.C., et al. Short-term safety and efficacy of a single intravitreal bevacizumab injection for the management of polypoidal choroidal vasculopathy. Ophthalmologica 2009, 223(2):85-92.
91. Spaide R.F., Donsoff I., Lam D.L., et al. Treatment of polypoidal choroidal vasculopathy with photodynamic therapy. Retina 2002, 22(5):529-535.
92. Spaide R.F., Yannuzzi L.A., Slakter J.S., et al. Indocyanine green videoangiography of idiopathic polypoidal choroidal vasculopathy. Retina 1995, 15(2):100-110.
93. Stanga P.E., Lim J.I., Hamilton P. Indocyanine green angiography in chorioretinal diseases: indications and interpretation: an evidence-based update. Ophthalmology 2003, 110(1):15-21.
94. Stern R.M., Zakov Z.N., Zegarra H., et al. Multiple recurrent serosangineous retinal pigment epithelial detachment in black woman. Am J Ophthalmol 1985, 100(4):560-569.
95. Tamura H., Tsujikawa A., Otani A., et al. Polypoidal choroidal vasculopathy appearing as classic choroidal neovascularization on fluorescein angiography. Br J Ophthalmol 2007, 91(9):1152-1159.
96. Tateiwa H., Kuroiwa S., Gaun S., et al. Polypoidal choroidal vasculopathy with large vascular network. Graefes Arch Clin Exp Ophthalmol 2002, 240(5):354-361.
97. Terasaki H., Miyake Y., Suzuki T., et al. Polypoidal choroidal vasculopathy treated with macular translocation: clinical pathological correlation. Br J Ophthalmol 2002, 86(3):321-327.
98. Tong J.P., Chan W.M., Liu D.T., et al. Aqueous humor levels of vascular endothelial growth factor and pigment epithelium-derived factor in polypoidal choroidal vasculopathy and choroidal neovascularization. Am J Ophthalmol 2006, 141(3):456-462.
99. Tsujikawa A., Nakanishi H., Ojima Y., et al. Macular polypoidal choroidal vasculopathy with a remote lesion. Clin Experiment Ophthalmol 2008, 36(9):817-823.
100. Tsujikawa A., Sasahara M., Otani A., et al. Pigment epithelial detachment in polypoidal choroidal vasculopathy. Am J Ophthalmol 2007, 143(1):102-111.
101. Tsujikawa A., Hirami Y., Nakanishi H., et al. Retinal pigment epithelial tear in polypoidal choroidal vasculopathy. Retina 2007, 27(7):832-838.
102. Ueta T., Iriyama A., Francis J., et al. Development of typical age-related macular degeneration and polypoidal choroidal vasculopathy in fellow eyes of Japanese patients with exudative age-related macular degeneration. Am J Ophthalmol 2008, 146(1):96-101.
103. Uyama M., Wada M., Nagai Y., et al. Polypoidal choroidal vasculopathy: natural history. Am J Ophthalmol 2002, 133(5):639-648.
104. Uyama M., Matsubara T., Fukushima I., et al. Idiopathic polypoidal choroidal vasculopathy in Japanese patients. Arch Ophthalmol 1999, 117(8):1035-1042.
105. Uyama M. Choroidal neovascularization, experimental and clinical study [in Japanese]. Acta Soc Ophthalmol Jpn 1991, 95(12):1145-1180.
106. Yamaoka S., Okada A.A., Sugahara M., et al. Clinical features of polypoidal choroidal vasculopathy and visual outcomes in the absence of classic choroidal neovascularization. Ophthalmologica 2009, 224(3):147-152.
107. Yang Z., Camp N.J., Sun H., et al. A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration. Science 2006, 314(5801):992-993.
108. Yannuzzi L.A., Freund K.B., Goldbaum M., et al. Polypoidal choroidal vasculopathy masquerading as central serous chorioretinopathy. Ophthalmology 2000, 107(4):767-777.
109. Yannuzzi L.A., Wong D.W.K., Sforzolini B.S., et al. Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration. Arch Ophthalmol 1999, 117(11):1503-1510.
110. Yannuzzi L.A., Nogueira F.B., Spaide R.F., et al. Idiopathic polypoidal choroidal vasculopathy: a peripheral lesion. Arch Ophthalmol 1998, 116(3):382-383.
111. Yannuzzi L.A., Ciardella A., Spaide R.F., et al. The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy. Arch Ophtahlmol 1997, 115(4):478-485.
112. Yannuzzi L.A., Sorenson J., Spaide R.F., Lipson B. Idiopathic polypoidal vasculopathy (IPCV). Retina 1990, 10(1):1-8.
113. Yodoi Y., Tsujikawa A., Kameda T., et al. Central retinal sensitivity measured with the microperimeter 1 after photodynamic therapy for polypoidal choroidal vasculopathy. Am J Ophthalmol 2007, 143(6):984-994.
114. Yodoi Y., Tsujikawa A., Otani A., et al. Chorioretinal anastomosis after photodynamic therapy for polypoidal choroidal vasculopathy: CRA after PDT for PCV. Int Ophthalmol 2007, 28(4):297-299.
115. Yuzawa M., Mori R., Kawamura A. The origins of polypoidal choroidal vasculopathy. Br J Ophthalmol 2005, 89(5):602-607.
116. Yuzawa M., Mori R., Haruyama M. A study of laser photocoagulation for polypoidal choroidal vasculopathy. Jpn J Ophthalmol 2003, 47(4):379-384.
117. Wakabayashi T., Gomi F., Sawa M., et al. Marked vascular changes of polypoidal choroidal neovascularization after photodynamic therapy. Br J Ophthalmol 2008, 92(7):936-940.
118. Wen F., Chen C., Wu D., Li H. Polypoidal choroidal vasculopathy in elderly Chinese patients. Graefes Arch Clin Exp Ophthalmol 2004, 242(8):625-629.